Neurocrine Biosciences, Inc. (NBIX): Price and Financial Metrics
Neurocrine Biosciences, Inc. (NBIX)
Today's Latest Price: $98.67 USD
Updated Oct 30 4:00pm
Add NBIX to WatchlistSign Up
POWR Components:
Trade Grade Buy & Hold Grade Peer Grade Industry Rank
Industry Rank:
Ranked of 240 in Medical - Pharmaceuticals
See all "A" rated Strong Buy stocks
NBIX Stock Summary
- With a price/sales ratio of 9.15, Neurocrine Biosciences Inc has a higher such ratio than 85.87% of stocks in our set.
- In terms of twelve month growth in earnings before interest and taxes, Neurocrine Biosciences Inc is reporting a growth rate of 400.63%; that's higher than 96.17% of US stocks.
- As for revenue growth, note that NBIX's revenue has grown 66.15% over the past 12 months; that beats the revenue growth of 91.99% of US companies in our set.
- If you're looking for stocks that are quantitatively similar to Neurocrine Biosciences Inc, a group of peers worth examining would be RP, FLGT, MASI, CALX, and SEDG.
- Visit NBIX's SEC page to see the company's official filings. To visit the company's web site, go to www.neurocrine.com.
NBIX Stock Price Chart Interactive Chart >
NBIX Price/Volume Stats
| Current price | $98.67 | 52-week high | $136.26 |
| Prev. close | $98.92 | 52-week low | $72.14 |
| Day low | $96.00 | Volume | 511,600 |
| Day high | $98.75 | Avg. volume | 816,792 |
| 50-day MA | $103.20 | Dividend yield | N/A |
| 200-day MA | $107.12 | Market Cap | 9.20B |
Neurocrine Biosciences, Inc. (NBIX) Company Bio
Neurocrine Biosciences discovers and develops pharmaceuticals for the treatment of neurological and endocrine-related diseases and disorders in the United States. The company was founded in 1992 and is based in San Diego, California.
Loading social stream, please wait...